drugset / Trial / NCT05103813

Protective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMI

NCT05103813 ↗

Phase 0 Unknown 100 enrolled Shenzhen People's Hospital
NaSingle-groupOpen-labelTreatment

Summary

Protective effect of Beraprost Sodium Tablets on coronary microcirculation function and ventricular remodeling after reperfusion therapy for acute ST segment elevation myocardial infarction

Timeline

Start
2022-05-01
Primary completion
2022-12-31
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Beraprost Sodium Tablets Unknown — —